BOCA RATON, Fla., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq:SRTS), a
medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial
radiation therapy (SRT), today announced that Joe Sardano, President and Chief Executive Officer, will present at the following
upcoming investor conferences in September:
| 19th Annual Rodman & Renshaw Global Investment
Conference |
| Date and Time: |
|
Monday, September 11, 2017 at 4:15 p.m. Eastern time |
| Venue: |
|
Lotte New York Palace Hotel in New York City |
| |
|
|
| Sidoti & Company Fall 2017 Conference |
| Date and Time: |
|
Thursday, September 28, 2017 at 11:25 a.m. Eastern time |
| Venue: |
|
New York Marriott Marquis at Times Square |
Due to Hurricane Irma's South Florida expected path, management is cancelling its presentation at the
6th Annual Liolios Gateway Conference on September 6, 2017.
Mr. Sardano’s presentation at the Rodman & Renshaw Global Investment Conference will be webcast live and
available for replay in the Investor Relations section of the Company’s website at sensushealthcare.com.
About Sensus Healthcare
Sensus Healthcare, Inc. is a medical device company that is committed to providing non-invasive and
cost-effective treatment for non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy X-ray technology known as
superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development. Sensus has
successfully incorporated SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, SRT
technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients.
For more information, visit http://www.sensushealthcare.com.
Contact:
LHA Investor Relations
Kim Sutton Golodetz
(212) 838-3777
kgolodetz@lhai.com
